The comparison of the effects of the dietary interventions in MASLD patients on glucose and lipid metabolism and inflammatory outcomes, including fasting glucose and insulin, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), HbA1c, triglycerides, total cholesterol, LDL-C and HDL-C, as well as high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and lipopolysaccharide (LPS), is presented in Table 5 and Table 6. Here, IL6 is linked to Insulin resistance.